-The Times of India The free trade agreement that European Union is pushing India to sign could put an end to India's status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade...
More »SEARCH RESULT
Total Matching Records found : 114
'India May Win Patent Claims Due to Knowledge Library'
-Outlook Hyderabad: India could win 105 claims on international patents due to its Traditional Knowledge Digital Library (TKDL), Prime Minister Manmohan Singh said here today, opening the high-level segment meeting at the Conference of Parties to Convention on Biological Diversity. "We decided to build this knowledge database because of the patent on the use of neem extract in Europe and another patent on the use of turmeric as a healing agent. Since...
More »IPAB dismisses Bayer's stay plea in Nexavar case
-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...
More »Dr Anand Teltumbde, Dalit intellectual, thinker and human rights activist interviewed by Prasanna D Zore
-Rediff.com On July 14, the Nagpur bench of the Bombay high court commuted the death sentence awarded to six convicts in the Khairlanji murder case to 25 years' rigorous imprisonment. On September 29, 2006, a mob brutally raped a mother and daughter before killing them along with her two sons. Surekha Bhotmange (then 42), Priyanka Bhotmange (17), Roshan Bhotmange (19) and Sudhir Bhotmange (21) belonged to one of the three Dalit families...
More »Natco targets drugs ripe for compulsory licensing-Viswanath Pilla
-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...
More »
